Type 2 diabetes mellitus is becoming the most common type of diabetes in school children

Acta Diabetologica

Volumn 41, Issue 3, 2004, Pages 85-90

  Pontiroli, A E ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Children; Metabolic syndrome; Obesity; Type 2 dibetes

Indexed keywords

METFORMIN;

ADOLESCENT; BODY WEIGHT; CAUCASIAN; CHILDHOOD DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; EPIDEMIC; ETHNOLOGY; EUROPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN RELEASE; INSULIN RESISTANCE; ITALY; LIFESTYLE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SIDE EFFECT; SITTING; SLEEP APNEA SYNDROME; SOCIAL PROBLEM; UNITED STATES;

ADOLESCENT; AGE FACTORS; AGE OF ONSET; CHILD; DIABETES MELLITUS, TYPE 2; HUMANS; LIFE STYLE; OBESITY; RISK FACTORS;

EID: 4644279354     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-004-0149-8     Document Type: Review

References (68)

1. Kuczmarski RJ, Carroll MD, Flegal KM,Troiano RP (1997) Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). Obes Res 5:542-548
2. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL (1998) Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22:39-47
3. Midthjell K, Kruger O, Holmen J, Tverdal A, Claudi T, Bjorndal A, Magnus P (1999) Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trondelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care 22:1813-1820
4. Istituto Auxologico Italiano (2001) 3° Rapporto italiano sull'obesità in Italia. Franco Angeli, Milan
5. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097-1105
6. Drenick EJ, Bale GS, Seltzer F, Johnson DG (1980) Excessive mortality and causes of death in morbidly obese men. JAMA 243:443-445
7. Manson JAE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Hennekens CH (1990) A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 322:882-889
8. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS (2002) Obesity and the risk of heart failure. N Engl J Med 347:305-313
9. DeFronzo RA (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687
10. Knowler WC, Pettitt DJ, Saad MF, Charles MA, Nelson RG, Howard BV, Bogardus C, Bennett PH (1991) Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr 53[6 Suppl]:1543S-1551S
11. Mancini M, Contaldo F, Di Biase G, Scalfi L, Presta E, Mattioli PL (1979) Frequency, relevance and reversibility of medical complications of obesity. In: Mancini M, Lewis B, Contaldo F (eds) Medical complications of obesity. Serono Symposia, vol 26. Academic Press, London, pp 1-26
12. Drenick EJ (1979) Definition and health consequences of morbid obesity. Surg Clin North Am 59:963-976
13. Long SD, O'Brien K, MacDonald KG, Leggett-Frazier N, Swanson MS, Pories WJ, Caro JF (1994) Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study. Diabetes Care 17:372-375
14. Pontiroli AE, Galli L (1998) Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidemia. Acta Diabetol 35:130-136
15. Sjostrom CD, Peltonen M, Wedel H, Sjostrom L (2000) Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 36:20-25
16. Pontiroli AE, Calderara A, Maffi P, Bonisolli L, Carenini A, Piatti PM, Monti LD, Gallus G, Pozza G, Illeni MT (1989) Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release. Diabete Metab 15:79-84
17. Arner P, Pollare T, Lithell H (1991) Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia 34:483-487
18. Banerji MA, Lebovitz HE (1992) Insulin action in black Americans with NIDDM. Diabetes Care 15:1295-1302
19. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74:1318-1328
20. Kronsbein P, Jorgens V, Muhlhauser I, Scholz V, Venhaus A, Berger M (1988) Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes. Lancet 2:14071411
21. Pontiroli AE, Calderara A, Pozza G (1994) Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management. Diabetes Metab Rev 10:31-43
22. Grundy SM (1997) Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 95:1-4
23. - (2003) American Diabetes Association Position Statements. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 26:S28-S32
24. - (1989) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854-865
25. - (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317:703-713
26. HOPE Study Investigators (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation. Lancet 355:253-257
27. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860
28. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HE, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869
29. Brown SA, Upchurch S, Anding R, Winter M, Ramirez G (1996) Promoting weight loss in type II diabetes. Diabetes Care 19:613-624
30. World Health Organization (1995) Physical status: the use and interpretation of anthropometry: report of a WHO expert committee. WHO, Geneva, pp 1-452 (Technical report series no. 854)
31. Guagnano MT, Pace-Palitti V, Carrabs C, Merlitti D, Sensi S (1999) Weight fluctuations could increase blood pressure in android obese women. Clin Sci (Lond) 96:677-680
32. Wadden TA (1993) Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials. Ann Intern Med 119:688-693
33. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Dohm L (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339-352
34. Dixon JB, O'Brien PE (2002) Health outcomes of everely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 25:358-363
35. Pontiroli AE, Pizzocri P, Librenti MC, Vedani P, Marchi M, Cucchi E, Orena C, Paganelli M, Giacomelli M, Feria G, Folli F (2002) Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87:3555-3561
36. MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ (1997) The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1:213-220
37. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537-544
38. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hàmalainen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350
39. Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403
40. Diabetes Prevention Program Research Group (2003) Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program. Diabetes Care 26:977-980
41. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP (2002) Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51:2796-2803
42. Chiasson JC, Josse RG, Gomis R, Hanefeld M, Karasik A, Laasko M (2002) Acarbose for the prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077
43. Barlow SE, Dietz WH (1998) Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics 102:E29
44. Moreno LA, Fleta J, Sarria A, Rodriguez G, Gil C, Bueno M (2004) Secular changes in body fat patterning in children and adolescents of Zaragoza (Spain). Int J Obes Rel Metab Dis 25:1656-1660
45. Cruz ML, Bergman RN, Goran MI (2002) Unique effect of visceral fat on insulin sensitivity in obese hispanic children with a family history of type 2 diabetes. Diabetes Care 25:1631-1636
46. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS (1999) The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 103:1175-1182
47. Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G (2003) Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 26:118-124
48. Fagot-Campagna A (2000) Emergence of type 2 diabetes mellitus in children: epidemiological evidence. J Pediatr Endocrinol Metab 13[Suppl 6]:1395-1402
49. Acton KJ, Burrows NR, Moore K, Querec L, Geiss LS, Engelgau MM (2002) Trends in diabetes prevalence among American Indian and Alaska native children, adolescents, and young adults. Am J Public Health 92:1485-1490
50. Lipton R, Keenan H, Onyemere KU, Freels S (2003) Incidence and onset features of diabetes in African-American and Latino children in Chicago, 1985-1994. Diabetes Metab Res Rev 18:135-142
51. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH (2003) Prevalence of a metabolic syndrome phenotype in adolescents. Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 157:821-827
52. Hathout EH, Thomas W, El-Shahawy M, Nahab F, Mace JW (2001) Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics 107:E102
53. Onyemere KU, Lipton RB (2002) Parental history and early-onset type 2 diabetes in African Americans and Latinos in Chicago. J Pediatr 141:825-829
54. Umpaichitra V, Banerji MA, Castells S (2002) Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 15[Suppl 1]:525-530
55. Banerji MA (2002) Impaired beta cell and alpha cell function in African-American children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 15[Suppl 1]:493-501
56. Castells S (2002) Management of hyperglycemia in minority children with type 2 diabetes. J Pediatr Endocrinol Metab 15[Suppl 1]:531-540
57. Wilkin TJ, Metcalf BS, Murphy, MJ, Kirkby J, Jeffery AN, Voss LD (2002) The relative contributions of birth weight, weight change, and current weight to insulin resistance in contemporary 5-year-olds: the EarlyBird Study. Diabetes 51:3468-3472
58. Fagot-Campagna A, Saaddine JB, Engelgau MM (2000) Is testing children for type 2 diabetes a lost battle? Diabetes Care 23:1442-1443
59. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802-810
60. Pinelli L, Elerdini N, Faith MS, Agnello D, Ambruzzi A, De Simone M, Leggeri G, Livieri C, Monetti N, Peverelli P, Salvatoni A, Seminara S, Uasone R, Pietrobelli A (1999) Childhood obesity: results of a multicenter study of obesity treatment in Italy. J Pediatr Endocrinol Metab 12[Suppl 3]:795-799
61. Kaufman FR (2002) Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab 15[Suppl 2]:737-744
62. Jones KL, Arslanian S, Peterokova VA, Park JS, Tomlinson MJ (2002) Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 25:89-94
63. Bradshaw B (2002) The role of the family in managing therapy in minority children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 15[Suppl 1]:547-551
64. Breaux CW (1995) Obesity surgery in children. Obes Surg 5:279-284
65. Sugerman HJ, Sugerman EL, DeMaria EJ, Kellum JM, Kennedy C, Mowery Y, Wolfe LG (2003) Bariatric surgery for severely obese adolescents. J Gastrointest Surg 7:102-107
66. Barlow SE, Trowbridge FL, Klish WJ, Dietz WH (2002) Treatment of child and adolescent obesity: reports from pediatricians, pediatric nurse practitioners, and registered dietitians. Pediatrics 110:229-235
67. Bunt JC, Salbe AD, Harper IT, Hanson RL, Tataranni PA (2003) Weight, adiposity, and physical activity as determinants of insulin sensitivity index of Pima Indian children. Diabetes Care 26:2524-2530
68. Chopra M, Galbraith S, Darnton-Hill I (2002) A global response to a global problem: the epidemic of overnutrition. Bull WHO 80:952-958